vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $18.3M, roughly 1.7× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -8.6%, a 5.6% gap on every dollar of revenue. On growth, FGI Industries Ltd. posted the faster year-over-year revenue change (-14.4% vs -25.6%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $2.2M). Over the past eight quarters, FGI Industries Ltd.'s revenue compounded faster (-0.5% CAGR vs -10.1%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
FGI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $18.3M |
| Net Profit | $-2.6M | $-554.0K |
| Gross Margin | 26.7% | 21.1% |
| Operating Margin | -2.2% | -2.2% |
| Net Margin | -8.6% | -3.0% |
| Revenue YoY | -14.4% | -25.6% |
| Net Profit YoY | -553.1% | 26.7% |
| EPS (diluted) | $-1.63 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.5M | $18.3M | ||
| Q3 25 | $35.8M | $15.9M | ||
| Q2 25 | $31.0M | $16.1M | ||
| Q1 25 | $33.2M | $18.9M | ||
| Q4 24 | $35.6M | $24.7M | ||
| Q3 24 | $36.1M | $28.3M | ||
| Q2 24 | $29.4M | $25.8M | ||
| Q1 24 | $30.8M | $22.7M |
| Q4 25 | $-2.6M | $-554.0K | ||
| Q3 25 | $-1.7M | $-1.8M | ||
| Q2 25 | $-1.2M | $-1.5M | ||
| Q1 25 | $-629.1K | $-1.5M | ||
| Q4 24 | $-402.3K | $-756.0K | ||
| Q3 24 | $-550.1K | $1.7M | ||
| Q2 24 | $163.6K | $343.0K | ||
| Q1 24 | $-412.2K | $-1.7M |
| Q4 25 | 26.7% | 21.1% | ||
| Q3 25 | 26.5% | 14.3% | ||
| Q2 25 | 28.1% | 15.6% | ||
| Q1 25 | 26.8% | 16.1% | ||
| Q4 24 | 24.6% | 14.7% | ||
| Q3 24 | 25.8% | 22.0% | ||
| Q2 24 | 30.5% | 17.6% | ||
| Q1 24 | 27.4% | 13.5% |
| Q4 25 | -2.2% | -2.2% | ||
| Q3 25 | 1.0% | -9.9% | ||
| Q2 25 | -2.7% | -8.4% | ||
| Q1 25 | -3.9% | -7.2% | ||
| Q4 24 | -3.5% | -2.1% | ||
| Q3 24 | -0.2% | 6.8% | ||
| Q2 24 | -1.5% | 2.0% | ||
| Q1 24 | -1.0% | -5.8% |
| Q4 25 | -8.6% | -3.0% | ||
| Q3 25 | -4.6% | -11.0% | ||
| Q2 25 | -4.0% | -9.3% | ||
| Q1 25 | -1.9% | -8.0% | ||
| Q4 24 | -1.1% | -3.1% | ||
| Q3 24 | -1.5% | 5.9% | ||
| Q2 24 | 0.6% | 1.3% | ||
| Q1 24 | -1.3% | -7.6% |
| Q4 25 | $-1.63 | $-0.01 | ||
| Q3 25 | $-0.86 | $-0.05 | ||
| Q2 25 | $-0.64 | $-0.05 | ||
| Q1 25 | $-0.07 | $-0.04 | ||
| Q4 24 | $-0.38 | $-0.02 | ||
| Q3 24 | $-0.29 | $0.04 | ||
| Q2 24 | $0.08 | $0.01 | ||
| Q1 24 | $-0.04 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $17.3M | $37.0M |
| Total Assets | $69.5M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $10.7M | ||
| Q3 25 | $1.9M | $13.6M | ||
| Q2 25 | $2.5M | $12.5M | ||
| Q1 25 | $1.2M | $11.4M | ||
| Q4 24 | $4.6M | $15.7M | ||
| Q3 24 | $3.0M | $12.3M | ||
| Q2 24 | $1.3M | $11.9M | ||
| Q1 24 | $3.3M | $6.6M |
| Q4 25 | $17.3M | $37.0M | ||
| Q3 25 | $19.7M | $37.0M | ||
| Q2 25 | $21.3M | $30.4M | ||
| Q1 25 | $21.8M | $31.5M | ||
| Q4 24 | $22.3M | $32.6M | ||
| Q3 24 | $23.5M | $29.1M | ||
| Q2 24 | $23.8M | $23.5M | ||
| Q1 24 | $23.9M | $20.6M |
| Q4 25 | $69.5M | $57.1M | ||
| Q3 25 | $73.0M | $57.5M | ||
| Q2 25 | $71.7M | $52.6M | ||
| Q1 25 | $68.5M | $54.0M | ||
| Q4 24 | $75.5M | $59.2M | ||
| Q3 24 | $74.7M | $57.1M | ||
| Q2 24 | $69.9M | $53.0M | ||
| Q1 24 | $68.6M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | $2.3M |
| Free Cash FlowOCF − Capex | $2.3M | $2.2M |
| FCF MarginFCF / Revenue | 7.5% | 12.0% |
| Capex IntensityCapex / Revenue | 0.2% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.3M | $2.3M | ||
| Q3 25 | $-1.9M | $-1.3M | ||
| Q2 25 | $7.6M | $1.8M | ||
| Q1 25 | $-7.4M | $-3.5M | ||
| Q4 24 | $617.4K | $865.0K | ||
| Q3 24 | $-915.0K | $4.3M | ||
| Q2 24 | $862.1K | $1.4M | ||
| Q1 24 | $-8.0M | $-2.4M |
| Q4 25 | $2.3M | $2.2M | ||
| Q3 25 | $-2.1M | $-1.5M | ||
| Q2 25 | $7.4M | $1.7M | ||
| Q1 25 | $-7.7M | $-3.5M | ||
| Q4 24 | $-214.1K | $470.0K | ||
| Q3 24 | $-1.1M | $4.1M | ||
| Q2 24 | $281.5K | $1.2M | ||
| Q1 24 | $-8.6M | $-2.5M |
| Q4 25 | 7.5% | 12.0% | ||
| Q3 25 | -5.9% | -9.6% | ||
| Q2 25 | 23.8% | 10.5% | ||
| Q1 25 | -23.3% | -18.8% | ||
| Q4 24 | -0.6% | 1.9% | ||
| Q3 24 | -3.0% | 14.4% | ||
| Q2 24 | 1.0% | 4.5% | ||
| Q1 24 | -28.0% | -11.1% |
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.7% | 1.4% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 1.1% | 0.3% | ||
| Q4 24 | 2.3% | 1.6% | ||
| Q3 24 | 0.5% | 0.7% | ||
| Q2 24 | 2.0% | 1.1% | ||
| Q1 24 | 2.0% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 5.27× | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
